Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (67)

« Back to Publications

Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.

Hou MM. et al, (2025), Nat Commun, 16

Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.

King LDW. et al, (2024), Cell Rep Med, 5

Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies

King LDW. et al, (2024)

Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection.

Hou MM. et al, (2023), Sci Transl Med, 15

Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies.

Ko K-T. et al, (2022), Nat Commun, 13

Impact of a blood-stage vaccine on Plasmodium vivax malaria.

Hou MM. et al, (2022)

Modular capsid decoration boosts adenovirus vaccine-induced humoral and cellular immunity against SARS-CoV-2

Dicks MDJ. et al, (2022)

Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein.

Wright D. et al, (2020), iScience, 23

Functional Characterization and Comparison of Plasmodium falciparum Proteins as Targets of Transmission-blocking Antibodies.

Nikolaeva D. et al, (2020), Mol Cell Proteomics, 19, 155 - 166

Functional Characterization and Comparison of Plasmodium falciparum Proteins as Targets of Transmission-blocking Antibodies.

Nikolaeva D. et al, (2020), Mol Cell Proteomics, 19, 155 - 166

A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response.

Marini A. et al, (2019), Front Immunol, 10

PLUG AND DISPLAY VIRUS-LIKE-PARTICLE VACCINES FOR OUTBREAK PATHOGENS

Taylor IJ. et al, (2019), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 101, 263 - 263

Production and characterisation of the first human monoclonal antibodies against Plasmodium falciparum transmission blocking antigen Pfs25

Zaric M. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1683 - 1684

DEMONSTRATION OF A BLOOD-STAGE CONTROLLED HUMAN MALARIA INFECTION MODEL FOR PLASMODIUM VIVAX VACCINE EFFICACY TESTING

Minassian AM. et al, (2019), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 101, 133 - 134

Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody.

Lennartz F. et al, (2018), Nat Commun, 9

Load More

1
2
3
4
5